Pharmacogenomics (ISSN 1462-2416) is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field. Pharmacogenomics focuses on those aspects that have the most direct relevance to the pharmaceutical industry and wider clinical community
| YEAR | Impact Factor |
|---|---|
| 2023-24 | 1.9 |
| 2022 | 2.1 |
| 2021 | 2.638 |
PHARMACOGENOMICS, 1462-2416, 2000-ongoing, Biochemistry, Genetics and Molecular Biology,Pharmacology, Toxicology and Pharmaceutics.